Brivaracetam
Brand name: Briviact
Rank #202 of 500 drugs by total cost
$71.8M
Total Cost
43,716
Total Claims
$71.8M
Total Cost
1,298
Prescribers
$1,644
Cost per Claim
2,148
Beneficiaries
47,719
30-Day Fills
$55K
Avg Cost/Provider
34
Avg Claims/Provider
About Brivaracetam
Brivaracetam (sold as Briviact) was prescribed 43,716 times by 1,298 Medicare Part D providers in 2023, costing the program $71.8M. At $1,644 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 199 | Pirfenidone (Pirfenidone) | $74.1M | 17,775 |
| 200 | Escitalopram Oxalate (Escitalopram Oxalate) | $73.6M | 4,975,143 |
| 201 | Fingolimod Hcl (Fingolimod) | $72.1M | 10,675 |
| 202 | Brivaracetam (Briviact) | $71.8M | 43,716 |
| 203 | Mirtazapine (Mirtazapine) | $70.2M | 3,166,739 |
| 204 | Immun Glob G(Igg)-Ifas/Glycine (Panzyga) | $70.1M | 4,693 |
| 205 | Buprenorphine Hcl (Buprenorphine Hcl) | $69.7M | 205,349 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology